William Clark
Urology · Anchorage, AKNPI 1073567079
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Astellas Pharma Global Development accounts for 64.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $6,620 and has fallen 99.8% since, to $14 in 2024. Among urology clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $186.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$6K
- Merck$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Astellas Pharma US Inc$223
- Pfizer$126
- Antares Pharma, Inc.$94
- plus $441 from 13 others
Across 568 payments — averaging $5520.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$830K
- Astellas Pharma Global Development$505K
- Bayer$449K
- Pfizer$418K
- Medivation LLC.$290K
- E.r. Squibb & Sons, L.L.C.$191K
- plus $453K from 9 others
What the payments were for
- Consulting fees$4,93052%
- Travel & lodging$3,10633%
- Food & beverage$1,37214%
- Education$841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 5 | $6,122 |
| Merck | 8 | $1,437 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,050 |
| Astellas Pharma US Inc | 5 | $223 |
| Pfizer | 4 | $126 |
| Antares Pharma, Inc. | 2 | $94 |
| Endo Pharmaceuticals Inc. | 4 | $72 |
| Terumo Medical Corporation | 1 | $66 |
| Cook Medical LLC | 2 | $49 |
| Johnson & Johnson | 3 | $39 |
| Seagen Inc. | 2 | $38 |
| Boston Scientific | 2 | $35 |
| Travere Therapeutics, Inc. | 5 | $34 |
| Ferring Pharmaceuticals Inc. | 1 | $31 |
| AstraZeneca | 2 | $27 |
| Endo USA, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| AbbVie | 1 | $13 |
| Tolmar Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,493 in reported general payments places this provider in the 95th percentile of 28 urology providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 78 | $3,154 |
| Tolterodine Tartrate ErTolterodine Tartrate | 13 | $2,501 |
| Potassium Citrate ErPotassium Citrate | 12 | $2,402 |
| Finasteride | 30 | $1,221 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $1,183 |
| Dutasteride | 22 | $986 |
| Allopurinol | 33 | $684 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $451 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $164 |
Paid to pharmacies, not to this prescriber.
Other urology in Anchorage
- Joshua LoganAnchorage$16K
- Elysia SpencerAnchorage$8K
- Andre GodetAnchorage$5K
- Bryan WilsonAnchorage$4K
- Mariam MillerAnchorage$4K
- Sarah BeebeAnchorage$3K
- Zachary PoseyAnchorage$2K
- Nancy GillcristAnchorage$2K
- Paul FerucciAnchorage$1K
- Owen AftrethAnchorage$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.